Great moment during the London protest.
Brick in the wall being sung in unison by the crowd. 🙌

Outside Chris Wittys house. https://t.me/onceyouawake1

Laurence Fox outside Downing Street.

Meanwhile on the BBC...
(Bob Moran Cartoons)

THE BIG WEEK DAY EVENT IS COMING TO LONDON!

We invite you to help make this the biggest ever weekday protest in our movement.
On the 19th of July @ 12pm we will be making a united stand as Boris delivers his 2nd speech to lift restrictions.

We stand in solidarity with all those that have suffered at the hands of the tyrannical government. We will be the voices for the voiceless. This ends when we say no!


#EndAllRestrictions
#NoMoreLockdowns
#WeStandUnited
#DividedWeFall
#DoNotComply

London protest 26.6.21

MATT HANCOCK HAS RESIGNED! 🇬🇧💪🏼👊

Courage is contagious,
Be corageous:
Spread Love, not fear..

#LOVEnotfear
t.me/lovenotfearmankind

Discussion of the suppression of evidence in the Oxford Andrew Hill paper by his sponsors Unitaid

https://www.bitchute.com/video/WKSAE1LP6DTt/

I don’t know about you, but I’m getting exasperated trying to explain to people that we’re being lied to.
Accompanying the lies is the near destruction of our economy & civil society.

Just two facts tells you beyond any possible doubt that the whole covid19 policy response fiasco is faked:

1. The infection fatality ratio as estimated by Dr John Ioaniddes is 0.15%. Typical seasonal influenza IFR is estimated at around 0.1%. Some years it’s less dangerous, others it’s more.
So the conclusion is that covid19 is, across the population, slightly worse than the typical flu season. Because the lethality of flu varies from year to year, it’s equally true to say that the lethality of covid19 is well within the envelope of the worst of the flu seasons, easily several over the last 20years.
More relevant yet, covid19 has a steeper age/ lethality relationship than does ‘flu.
This means that the over 70s are appreciably more at risk from covid19 than from flu.
The corollary though is that the entire working age population is at a LESSER risk than they are from flu.
Ioaniddes is among the most respected medical doctor / epidemiologist working today. His assessment is or was on WHO’s website for ages, hiding in plain sight.
There was never a need to lockdown any of the working aged population.

2. There are several, safe & effective treatments. Information on these has been censored & those trying to tell us about these off-patent, low-cost agents get smeared.
Nevertheless there is higher quality clinical trials data on many of them than there if analogously for the covid19 vaccines.
Hydroxychloroquine, azithromycin, zinc, Vitamin D, ivermectin, budesonide, apixaban, fluvoxamine (doubtless others).
Used with skill, reductions in hospitalisation & death from covid19 ranging from 75% to 90% have been reported, and with overwhelmingly good safety profiles.

So if the virus isn’t exceptionally lethal (it simply isn’t) & if there are numerous safe & effective treatments to keep people out of the hospital & to save lives (and there are), what’s all this theatre about?

Answers on the back of a copy of Klaus Schwab’s latest book.

Mike

Robin Monotti with Uwe Alschner on Klartext: DEFENDING SOCIETY.

English / German Version of an Interview with Robin Monotti on Democracy, Responsibility and Freedom. 

FULL VIDEO:
https://odysee.com/@klartext:d/defending-society:c

This interview was held some weeks ago with Robert F Kennedy Jr.
I’ve not heard this, having left a large number of interviews in my wake.
Cheers,
Mike

This Nature paper about ivermectin focuses on ‘mechanisms of action’ as a medicine to prevent & treat covid19.
It’s not uncommon that the molecular mechanism(s) of actions even of clinically well-characterised therapeutics is not known or not fully understood. Usually the target with which the agent interacts is discovered when, as in this case, the empirical observation that ivermectin had utility against parasitic diseases preceded the deep investigations in the lab.
There are very good reasons for trying to uncover how natural product based therapeutics work, not least that it usually provides a rational path to follow in order to find improved forms.
Another example of a drug class which trod the same path is cyclosporines. Also complex natural products, the first example became a licensed medicine long before the mechanism of action was uncovered.
I should acknowledge in passing that very many classes of prescription drugs have their origins in natural product discovery. The penicillin class of antibiotics is of course another example. Also opioid agonists as relievers of strong pain. The list is very long. I make this point so that students of ivermectin appreciate that it used to be commonplace & not the exception that natural products & their clinical utility often preceded what we now might think of as ‘rational drug design’.
Enjoy,
Mike

Ivermectin is, literally, a remedy from mother Earth: it comes from the soil:

"Discovered in the late-1970s, the pioneering drug ivermectin, a dihydro derivative of avermectin—originating solely from a single microorganism isolated at the Kitasato Intitute, Tokyo, Japan from Japanese soil—has had an immeasurably beneficial impact in improving the lives and welfare of billions of people throughout the world.

There are few drugs that can seriously lay claim to the title of ‘Wonder drug’, penicillin and aspirin being two that have perhaps had greatest beneficial impact on the health and wellbeing of Mankind. But ivermectin can also be considered alongside those worthy contenders, based on its versatility, safety and the beneficial impact that it has had, and continues to have, worldwide—especially on hundreds of millions of the world’s poorest people. Several extensive reports, including reviews authored by us, have been published detailing the events behind the discovery, development and commercialization of the avermectins and ivermectin (22,23-dihydroavermectin B), as well as the donation of ivermectin and its use in combating Onchocerciasis and lymphatic filariasis.1–6) However, none have concentrated in detail on the interacting sequence of events involved in the passage of the drug into human use.
When it first appeared in the late-1970s, ivermectin, a derivative of avermectin (Fig. ​(Fig.1 )1 ) was a truly revolutionary drug, unprecedented in many ways. It was the world’s first endectocide, forerunner of a completely new class of antiparasitic agents, potently active against a wide range of internal and external nematodes and arthropods. In the early-1970s, a novel international Public Sector–Private Sector partnership was initiated by one of us (Ōmura, then head of the Antibiotics Research Group at Tokyo’s Kitasato Institute), forming a collaboration with the US-based Merck, Sharp and Dohme (MSD) pharmaceutical company. Under the terms of the research agreement, researchers at the Kitasato Institute isolated organisms from soil samples and carried out preliminary in vitro evaluation of their bioactivity. Promising bioactive samples were then sent to the MSD laboratories for further in vivo testing where a potent and promising novel bioactivity was found, subsequently identified as being caused by a new compound, which was named ‘avermectin’.7) Despite decades of searching around the world, the Japanese microorganism remains the only source of avermectin ever found.1) Originating from a single Japanese soil sample and the outcome of the innovative, international collaborative research partnership to find new antiparasitics, the extremely safe and more effective avermectin derivative, ivermectin, was initially introduced as a commercial product for Animal Health in 1981. 

Ivermectin proved to be even more of a ‘Wonder drug’ in human health, improving the nutrition, general health and wellbeing of billions of people worldwide ever since it was first used to treat Onchocerciasis in humans in 1988. It proved ideal in many ways, being highly effective and broad-spectrum, safe, well tolerated and could be easily administered (a single, annual oral dose)."

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043740/